New search | Conferencedetail
Print view
 
 

Neuromuscular Drug Development Summit

evvnt Platform / evvnt
-
29.10.2018 - 31.10.2018  The Colonnade Boston Hotel, 120 Huntington Avenue, 02116 Boston, USA
08:00 to 13:00
 
Conference themes
Neuromuscular diseases are a huge unmet clinical need, with huge advances and excitement in the field now is the time combine forces and help accelerate development of truly curative neuromuscular therapeutics.

The inaugural Neuromuscular Drug Development Summit is industry's first dedicated discussion and networking forum focused on bringing together neuromuscular thought-leaders to share the latest scientific progress and address the current challenges drug developers are facing.
Professional congress organizer (PCO)
Neuromuscular Drug Development Summit
Notes
Brochure: https://go.evvnt.com/244848-2?pid=4832

Speakers: Greg La Rosa Chief Scientific Officer, Senior Vice President, Rare Disease Research and Development Pfizer, Brian Kaspar Chief Scientific Officer Avexis, and more.
 

Enquiries and Registration:

https://go.evvnt.com/244848-0?pid=4832
Mr. Hanson Wade
 
Categories
General Medicine
Languages
English
Congress fees
Conference + 2 Workshops Early Bird Pricing: USD 3599.0, Conference + 2 Workshops Standard Pricing: USD 3899.0
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AMREF - African Medical and Research FoundationÖsterreichische Akademie der ÄrzteFFG - 7. EU-RahmenprogrammÖsterreichisches Rotes KreuzAnästhesie in Entwicklungsländern e. V.newTreeHilfswerk AustriaHelix - Forschung & Beratung Wien

Facebook

Give us your professional opinion

Start survey

Start survey